Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial

K Dickstein, J Kjekshus - The Lancet, 2002 - thelancet.com
Background ACE inhibitors attenuate the detrimental effects of angiotensin II, and improve
survival and reduce morbidity in patients with acute myocardial infarction and evidence of …

[引用][C] Angiotensin converting enzyme inhibitors in acute myocardial infarction.

KK Sethi, R Mehrotra - Indian heart j, 1994

Early use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: evidence from clinical trials

GV Moukarbel, SD Solomon - Current heart failure reports, 2008 - Springer
Following acute myocardial infarction, patients are at increased risk of developing heart
failure, which is more prevalent in those with reduced ventricular systolic function. Activation …

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction

N Bissessor, H White - Vascular health and risk management, 2007 - Taylor & Francis
The physiological role of the renin angiotensin aldosterone system (RAAS) is to maintain the
integrity of the cardiovascular system. The effect of angiotensin II is mediated via the …

Valsartan, Captopril, or Both in Myocardial Infarction [2](multiple letters)

JH McAnulty, R Moshenyat, Y Kupfer… - … England Journal of …, 2004 - einstein.elsevierpure.com
Results:-AdverseEffects: An unspecified number of patients had hypotension, renal
dysfunction, hyperkalemia, and cough. FreeText: Comments on Diovan and reply. The study …

[PDF][PDF] ACE inhibitors vs. angiotensin II receptor blockers in acute myocardial infarction and heart failure

JA Gold, PS Rahko - WMJ-MADISON-, 2004 - researchgate.net
The differences in outcome using losartan, as compared to the new trials with valsartan and
candesartan, also raise the question of whether the results achieved by valsartan and …

Angiotensin-converting enzyme inhibitors after myocardial infarction: indications and timing

SG Ball, AS Hall, GD Murray - Journal of the American College of …, 1995 - Elsevier
A number of major studies have examined the impact of angiotensin-converting enzyme
inhibitors on mortality in patients with ischemic heart disease. However, in these studies …

[HTML][HTML] Angiotensin receptor–neprilysin inhibition in acute myocardial infarction

MA Pfeffer, B Claggett, EF Lewis… - … England Journal of …, 2021 - Mass Medical Soc
Background In patients with symptomatic heart failure, sacubitril–valsartan has been found
to reduce the risk of hospitalization and death from cardiovascular causes more effectively …

Angiotensin Receptor-Neprilysin Inhibitor in Acute Myocardial Infarction.

P Pathak - The Journal of the Association of Physicians of India, 2022 - europepmc.org
Angiotensin Receptor-Neprilysin Inhibitor in Acute Myocardial Infarction. - Abstract - Europe
PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers …

[PDF][PDF] Angiotensin-receptor blockade in acute myocardial infarction-a matter of dose

DL Mann, A Deswal - New England Journal of Medicine, 2003 - researchgate.net
Beta-blockers, angiotensin-converting–enzyme (ACE) inhibitors, and aldosterone
antagonists have been shown to reduce the overall risk of death as well as the risk of major …